drugset / Trial / NCT00893724

Supplemental Adjuvants for Intracellular Nutrition and Treatment

NCT00893724 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

Nutritional supplements have an augmentative effect on the outcomes of standard treatment of diabetic macular edema (DME) and Neovascular Age-Related Macular Degeneration (NAMD).

Timeline

Start
2009-06
Primary completion
2011-08
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator CoQ10 Other / unclassified 50 mg —
Comparator Inosine Unknown 500 mg —
Comparator Minocycline Small molecule 50 mg —
Comparator N-acetylcysteine Small molecule 600 mg —
Comparator Niacinamide Unknown 750 mg —
Comparator Tocopherol Unknown 200 iu —
Comparator Tocotrienol Small molecule 10 mg —
Comparator Vitamin C Other / unclassified 1000 mg —